AVAILABLENCT07159139
Vatiquinone Expanded Access Protocol
Studying Mitochondrial disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Medical University of South Carolina
- Principal Investigator
- Thomas Koch, MDMedical University of South Carolina
- Intervention
- Vatiquinone(drug)
- Eligibility
- 1 years · All sexes
Collaborators
PTC Therapeutics
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07159139 on ClinicalTrials.govOther trials for Mitochondrial disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06890520Neurometabolic Profile of Individuals With Primary Mitochondrial DiseaseChildren's Hospital of Philadelphia
- RECRUITINGPHASE1NCT06819683Validation of Nanosensor Oxygen MeasurementChildren's Hospital of Philadelphia
- RECRUITINGNANCT06535646Digital Health Technology for People With Mitochondrial DiseaseNeuroscience Research Australia
- RECRUITINGNCT06504433The Natural History of Mitochondrial DiseasesNeuroscience Research Australia
- RECRUITINGPHASE1NCT04086329Validation of Oxygen Nanosensor in Mitochondrial MyopathyChildren's Hospital of Philadelphia
- RECRUITINGPHASE3NCT05430620Intermittent Versus Continuous Surface O2 During HMP of DCD KidneysCliniques universitaires Saint-Luc- Université Catholique de Louvain
- RECRUITINGNCT04920812MITOMICS : a Multi-OMICS Approach for the Diagnosis of Mitochondrial DiseasesCentre Hospitalier Universitaire de Nice
- RECRUITINGNCT05958706Mitochondrial Substrate Utilization in the Diabetic Human HeartHeinrich-Heine University, Duesseldorf